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O B J E C T I V E S This investigation sought to study the incremental value of gated rubidium (Rb)-82
positron emission tomography (PET) myocardial perfusion imaging (MPI) over clinical variables for
predicting survival and future cardiac events.
B A C KG ROUND The prognostic value of Rb-82 PET-MPI and left ventricular ejection fraction (LVEF)
reserve (stress minus rest LVEF) is not well deﬁned.
METHOD S 1,432 consecutive patients undergoing gated rest/vasodilator stress rubidium-82 PET
were followed up for at least 1 year. Of these, rest and peak stress LVEF and LVEF reserve were available
in 985 patients. Cardiac events (CE) including cardiac death or nonfatal myocardial infarction and
all-cause death were assessed.
R E S U L T S Over a mean follow-up of 1.7  0.7 years, 83 (5.8%) CE and 140 (9.7%) all-cause death
were observed. There was an increase in risk for both end points with an increasing percentage of
abnormal and ischemic myocardium. With normal, mild, moderate, or severely ischemic scans, the
observed annualized rates of CE were 0.7%, 5.5%, 5%, and 11% and of all-cause death were 3.3%, 7.2%,
6.9%, and 12.5%, respectively. In 985 patients with peak stress gated data, the observed annualized rates
of CE (2.1% vs. 5.3%, p  0.001) and all-cause death (4.3% vs. 9.2%, p  0.001) were higher in patients
with an LVEF reserve0% compared with those with an LVEF reserve0%. On Cox proportional hazards
analysis, after consideration of clinical, historical, and rest LVEF information, stress PET results and LVEF
reserve yielded incremental prognostic value with respect to both CE and all-cause death.
CONC L U S I O N S Vasodilator stress Rb-82 PET-MPI provides incremental prognostic value to
historical/clinical variables and rest LVEF to predict survival free of CE and all-cause death. An increasing
percentage of ischemia on PET-MPI is associated with an increase in the risk of CE and all-cause death.
Left ventricular ejection fraction reserve provides signiﬁcant independent and incremental value to
Rb-82 MPI for predicting the risk of future adverse events. (J Am Coll Cardiol Img 2009;2:846–54)
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847yocardial perfusion imaging (MPI)
with dedicated positron emission to-
mography (PET) (1) and integrated
PET/computed tomography (CT) (2)
re highly accurate for detection of obstructive
oronary artery disease (CAD) (1,3). Also, MPI
ith dedicated PET and PET/CT seem to be more
ccurate than single-photon emission tomography
SPECT) in the diagnosis of obstructive CAD,
See page 855
specially among those undergoing pharmacologic
tress (4–6). Because of the increased availability of
ET scanners, as well as improved access to the
enerator-produced radiotracer rubidium (Rb)-82,
he clinical use of MPI with PET is increasing.
Although the incremental prognostic value of
PECT-MPI is well established, data regarding the
rognostic value of PET-MPI are limited (7–10).
n the early studies, the patient cohort was com-
rised of high-risk patients with known CAD,
eflecting the pattern of PET use in the early 1990s
9). A more recent study (8) reported the incremen-
al value of PET but was limited in size and
tatistical power (cardiac death or myocardial in-
arction [MI], n  17), precluding optimal multi-
ariable modeling. Therefore, the incremental
rognostic value of Rb-82 PET over clinical vari-
bles remains largely undefined.
Our objectives were to define the incremental
alue of MPI and left ventricular (LV) function
ssessed with Rb-82 PET for the prediction of
urvival free of cardiac events (CE) and all-cause
eath in a large cohort of patients referred for
est/vasodilator stress Rb-82 PET.
E T H O D S
atient cohort. A total of 1,598 consecutive patients
nderwent gated rest and vasodilator stress Rb-82
PI between November 2003 and October 2006 at
he Brigham and Women’s Hospital. Patients with
rior cardiac transplantation, moderate or severe
alvular heart disease (n  45, 2.8%), atrial fibril-
ation (n  74, 4.6%), and those with a follow-up
eriod 365 days (n  47, 2.9%) were excluded.
atients with coronary revascularization after the
ndex PET scan were included. The remaining
,432 patients, including 985 with rest and peak
tress LV ejection fraction (EF), comprised the
tudy cohort for this analysis. A subset of these
atients (n  510) comprised the patient popula- cion of a prior publication on the relation between
schemic burden and left ventricular ejection frac-
ion (LVEF) reserve (3). The Human Research
ommittee of Brigham and Women’s Hospital
pproved this study.
b-82 PET/CT MPI protocol. Patients were instructed
o fast for 6 h and withhold caffeine-containing
everages (24 h before the test) and antianginal
edications (beta-blockers, calcium blockers, and
itrates on the morning of the test) and were
tudied using a whole-body PET/CT scanner (Dis-
overy ST, GE Healthcare, Milwaukee, Wisconsin)
3). The majority of patients were referred for
harmacological stress testing. In 90 patients (6%)
ho were able to exercise, PET-MPI served as a
ollow-up for an equivocal SPECT MPI.
harmacological stress was performed us-
ng standard dipyridamole (142 g/kg/
in for 4 min in 1,212 patients, 85%) or
denosine (140 g/kg/min for 6 min in
20 patients, 15%).
Emission images were obtained after in-
ravenous administration of 1,480 to 2,220
Bq (40 to 60 mCi) of Rb-82 at rest and
tress, starting at 90 to 120 s after comple-
ion of the radionuclide infusion (120 s with
nown LVEF of 25%) and continued for
min. Gated images were acquired using
-frame gating. The CT portion of the
ET-CT examination in this analysis was
sed solely for correction of photon attenu-
tion by soft tissues. Commercial software
ACQC, GE Healthcare) was used for ap-
ropriate registration of the transmission
nd emission images when available. Images
ere reconstructed using ordered subsets
xpectation maximization (OSEM) (30 it-
rations and 2 subsets), and a 3-dimensional
ET filter was used (Butterworth filter cut-
ff frequency 10, order of 5).
nalysis of myocardial perfusion and gated images.
mages were interpreted semiquantitatively by 2
xperienced observers using a standard 17-segment
odel and a 5-point scoring system. Global
ummed stress score (SSS), summed rest score
SRS) and summed difference score (SDS) (the
ifference between SSS and SRS) were computed.
lthough vasodilator stress testing produces flow
eterogeneity and only rarely true ischemia, we
efer to reversibility as ischemia, and use it as an
perational term throughout the article. The SSS,
RS, and SDS were converted into percentages to
A B B
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848carred, or ischemic determined as: (100/68) 
SS, (100/68)  SRS, or (100/68)  SDS, respec-
ively (11). Based on the percent myocardium ab-
ormal, the overall scan results were categorized
nto normal (0%), mild (1% to 10%), moderate
11% to 20%), or severely abnormal (20%). Sim-
larly, scans were categorized as having no (0%),
ild (1% to 5%), moderate (5.1% to 10%), or severe
10%) ischemia or scar, respectively. Rest and
tress LV volumes and EF were calculated using
ommercially available software as described previ-
usly (3). The LVEF reserve was computed as stress
inus rest LVEF.
atient follow-up and outcome measures. All pa-
ients were followed up for a minimum of 1 year
fter the index PET study. Outcomes were deter-
ined by a review of electronic medical records,
ailed questionnaire, or a pre-scripted telephone
nterview. The end points of this study included CE
a composite of cardiac death or nonfatal MI) and
ll-cause death. In patients with multiple events
n  4), only the first event was considered for
urvival analysis. Cardiac-specific end points were
erified by a review of the electronic medical records
nd death certificates. Event rates were annualized
y dividing the observed events by the mean dura-
ion of follow-up for each group.
tatistical analyses. Continuous variables are re-
orted as mean  SD and were compared using
-way analysis of variance. Categorical variables are
eported as a proportion and compared using a
hi-square test. A 2-tailed value of p  0.05 was
onsidered to be significant.
urvival analysis. Cox proportional hazards model-
ng stratified by early revascularization was used to
ssess the association of PET information and
vent-free survival time after adjustment for base-
ine characteristics (based on statistical or clinical
rounds, as well as known confounders of this
elationship) (12). Distinct models were determined
or each of the end points of CE and all-cause
eath. Incremental prognostic value was defined as
significant increase in the Wald statistic and
ikelihood ratio tests or an increase in the area under
he curve of receiver-operator characteristics (ROC)
nalysis, after the addition of imaging data to an
ptimized model of pre-imaging data alone. The
odels were carefully examined for proportional
azards assumption, multicollinearity, and the ad-
itive value of the terms.
We considered information in the order of clin-
cal evaluation: step 1, clinical rest EF and step 2,
tress test and perfusion data. Step 1 included the plinical risk factors (age, female sex, body mass
ndex, diabetes, hypertension, hypercholesterol-
mia, family history, cigarette smoking), historical
nformation (prior MI, revascularization, vascular
r renal disease) and rest LVEF. Step 2 consisted of
he addition of the stress test (peak heart rate,
T-segment depression) and perfusion data. Sepa-
ate models were developed with percent myocar-
ium ischemic and percent myocardium scarred, or
ercent myocardium abnormal, respectively. In 985
atients, LVEF reserve was added to the best
ET-MPI model including clinical factors, rest
VEF, stress variables, and PET-MPI (percent
yocardium ischemic and percent myocardium
carred or percent myocardium abnormal). We
aintained a ratio of 10 events per degree of
reedom of the model whenever possible. The
hreshold for covariate model entry into was p 
.05, and the threshold for covariate removal was
 0.10 (13). The S-PLUS 2000 (Release 2)
oftware package (Insightful Corp., Seattle, Wash-
ngton) with supplemental libraries was used for all
nalyses.
E S U L T S
atient population. The baseline characteristics of
he study cohort are shown in Table 1. The mean
ge of the 1,432 patients was 63 years, with 52%
emale subjects. The pre-test likelihood of CAD
as calculated using the logistic-based formula
eveloped and reported by Pryor et al. (14). The
ercentage of patients with known CAD (prior
oronary artery bypass graft, percutaneous coronary
ntervention, or Q-wave MI) or high, intermediate,
r low pre-test likelihood of CAD was 30.6%, 6%,
7.5%, and 16%, respectively.
ated PET-MPI. Overall, 46% (N  664) of the
tudy cohort had a normal MPI study and 54%
n  768) had an abnormal MPI study. Of the
ntire cohort of patients, 27% (n  381), 14% (n 
03), and 13% (n  184) showed mild, moderate,
r severely abnormal scans, respectively. No isch-
mia, mild, moderate, or severe ischemia was noted
n 11% (n  143), 17% (n  249), 13% (n  188),
nd 13% (n  188) of patients, respectively. No
car, small, medium, or large scar was noted in 17%
n  238), 18%, (n  263), 6% (n  91), and 12%
n  176) of patients, respectively. The mean
VEF of this cohort was 60  14%.
utcome events. The mean follow-up was 1.7 
.7 (range 1 to 3.3) years. Among the 1,432
atients, there were a total of 83 CE (5.8%, includ-
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849ng 4 patients, had both an MI and a subsequent
ardiac death), 43 cardiac deaths (3%), 44 nonfatal
I (3.1%), and 140 all-cause death (9.8%). Among
he 985 patients with rest and peak stress gated
Table 1. Baseline Characteristics of Patients With and Without E
Characteristic
Cardiac Even
No
(n  1,349)
Yes
(n  83
Demographics
Age (yrs) 63 13 66 1
Female sex (%) 54 35
BMI (kg/m2) 31 8 28 8
Obese (%) 46 39
Coronary risk factors (%)
History of hypertension 79 83
History of diabetes 34 51
History of dyslipidemia 62 70
History of smoking 15 27
Family history of CAD 34 27
Prior CAD (%)
History of prior PCI 18 35
History of prior CABG 12 31
Q-wave MI on ECG 6 15
Reason for test (%)
Chest pain 40 28
Dyspnea 28 29
Pre-operative evaluation 17 23
Other reasons 15 20
Stress PET hemodynamics
Rest heart rate (beats/min) 68 12 71 1
Peak heart rate (beats/min) 80 14 77 1
Rest systolic BP (mm Hg) 148 25 136 2
Peak systolic BP (mm Hg) 138 26 124 2
MPI scan results
Abnormal MPI (%) 51 90
Percent myocardium abnormal 7 11 19 1
Percent myocardium ischemic 4 6 9 1
Percent myocardium scarred 3 8 11 1
Gated MPI results
Rest
LVEDV (ml) 106 49 153 7
LVESV (ml) 46 38 91 7
LVEF (%) 61 13 47 1
Stress
LVEDV (ml) 112 57 147 9
LVESV (ml) 45 42 89 8
LVEF (%) 64 14 47 1
LVEF reserve (%) 5 7.0 2 8
Other reasons included abnormal electrocardiogram, palpitation, pre-transpla
categorical variables as proportions.
BMI  body mass index; BP  blood pressure; CABG  coronary artery bypas
ventricular end-diastolic volume; LVEF left ventricular ejection fraction; LVESV
perfusion imaging; PCI  percutaneous coronary intervention; PET  positronata, there were a total of 48 CE (including 23 tardiac deaths and 29 nonfatal MIs; 4 patients had
oth an MI and a subsequent cardiac death) and 81
ll-cause death.
nivariable analysis. Table 1 summarizes the charac-
ts
All-Cause Death
p Value
No
(n  1,292)
Yes
(n  140) p Value
0.01 62 13 68 13 0.0001
0.0001 53 43 0.01
0.003 32 9 27 7 0.0001
0.2 48 24 0.0001
0.3 79 81 0.5
0.001 34 44 0.01
0.1 63 54 0.04
0.001 15 19 0.3
0.2 34 24 0.02
0.0001 18 24 0.1
0.0001 12 19 0.03
0.005 6 13 0.003
0.03 40 24 0.0001
0.8 28 30 0.7
0.2 16 31 0.0001
0.2 16 15 0.3
0.1 68 12 74 14 0.0001
0.02 80 15 80 15 0.6
0.0001 148 25 143 28 0.02
0.0001 138 25 130 29 0.001
0.0001 52 72 0.0001
0.0001 7 11 13 13 0.0001
0.0001 4 6 6 9 0.0001
0.0001 3 8 6 11 0.0001
0.0001 111 53 125 71 0.004
0.0001 50 43 70 66 0.0001
0.0001 60 14 52 18 0.0001
0.0001 114 58 118.9 82 0.4
0.0001 46 43 63.5 68 0.001
0.0001 64 14 55.3 17 0.0001
0.004 5 7 2.0 7 0.001
valuation, arrhythmias. Continuous variables are listed as mean  SD, and
rgery; CAD  coronary artery disease; ECG  electrocardiogram; LVEDV  left
t ventricular end-systolic volume; MImyocardial infarction; MPImyocardial
sion tomography.ven
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850ients who experienced CE were older, less often
emale, and more frequently had diabetes, a history of
moking, prior coronary revascularization, and Q
aves on electrocardiogram. Further, they had a lower
ean body mass index, and had a lower peak heart
ate and a lower rest and peak systolic blood pressure
ompared with those who did not experience CE.
ith respect to the nuclear scan results, patients who
xperienced events had more frequently abnormal
PI results, with a higher percent of myocardium
bnormal, percent myocardium scarred, and percent
yocardium ischemic. Also, the mean LV volumes
ere higher, and the mean LVEF was lower in
atients with events compared to those without
vents. The mean LVEF reserve was lower in patients
ith events compared to those without those events.
Days
    
 
 
 
 
    
     
      
     
          
Survival as a Function of Percent Myocardium Abnormal
urves showing unadjusted cumulative survival free of cardiac
on of percent myocardium abnormal. Overall survival free of CE
with 0% abnormal myocardium. Event-free survival worsened
vent Rates as a Function of Percent Myocardium Abnormal, Isch
Percent Myocardium Abnormal Percent Myocar
tients CD MI
All-Cause
Death Patients CD
n n % n % n % n n %
64 2 0.2 6 0.5 39 3.5 664 2 0.2
81 9 1.3 10 1.4 37 6.1 249 13 2.9
03 13 3.6 11 3.0 31 9 188 8 2.4
84 19 6.4 17 5.8 33 11.9 188 13 4.3
d only ischemia‡ are not shown. Patients  1,432; cardiac death (CD)  83; all-d
t abnormal myocardium.requencies of CE and all-cause death according to MPI
esults. The observed frequencies of CE and all-cause
eath increased as a function of the percentage of
bnormal (stress perfusion defect), scarred (rest perfu-
ion defect), and ischemic myocardium (reversible
erfusion defect) (Table 2). In the mildly ischemic
cans, the observed annualized rates of CD, MI, and
ll-cause death were 2.9%, 2.2%, and 7.8% compared
ith 2.4%, 3.3%, and 6.6% in moderately ischemic
cans. However, when risk adjusted, the predicted
ates of CE and all-cause death were 3.5% and 6.2% in
ildly ischemic versus 3.9% and 6.1% in moderately
schemic scans. Kaplan-Meier survival curves showed
est survival free of CE in the normal group with a
orse event-free survival with increasing percent of
yocardium abnormal (Fig. 1).
elation of MPI to rest LVEF and LVEF reserve. A total
f 166 patients had abnormal rest LV function
LVEF 40%). An abnormal MPI compared with
ormal MPI was associated with a higher frequency
f CE both in patients with rest LVEF 40% (0%
s. 12%, p  0.03) and 40% (0.6% vs. 4.5%, p 
.001). An abnormal MPI compared with normal
PI was also associated with a higher frequency of
ll-cause death in patients with rest LVEF 40%
3.5% vs. 7.7%, p  0.001) but not in those with
VEF 40% (6.7% vs. 13.5%, p  0.3). This was
ikely caused by the small number (N  17) of
atients with LVEF 40% and normal PET-MPI.
The unadjusted annualized frequency of CE and
ll-cause death was higher in patients with LVEF
eserve 0 (a decrease in LVEF from rest to peak
tress) compared to those without a change or an
ncrease in LVEF reserve (Fig. 2).
ultivariable survival analysis. CE. Cox proportional
azards modeling showed that clinical and histori-
al variables and rest LVEF were predictive of this
nd point (Table 3). The addition of stress PET
c, or Scarred
Ischemic Percent Myocardium Scarred
I
All-Cause
Death Patients CD MI
All-Cause
Death
% n % n n % n % n %
0.5 39 3.5 664 2 0.2 6 0.5 39 3.5
2.2 31 7.8 240 11 2.6 6 1.4 30 7.9
3.3 21 6.6 91 3 1.8 6 3.7 12 7.8
4.3 31 11.0 176 18 6.4 15 5.3 28 10.6
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851yocardium scarred (Table 3) incrementally en-
anced the above clinical model. The modeling
esults for CE were very similar when percent
yocardium abnormal was substituted for percent
yocardium ischemic and scarred.
In 985 patients, the best PET-MPI model, includ-
ng clinical factors, rest LVEF, stress variables, and
ET-MPI, was predictive of CE (Table 3). Addition
f LVEF reserve to the best PET model incrementally
nhanced the prediction of CE.
ll-Cause Death. Cox proportional hazards model-
ng identified age, body mass index, insulin use, rest
eart rate, and rest LVEF as the optimal clinical
odel (chi-square 129.2, p  0.0001) for all-cause
eath. With the addition of vasodilator stress and
ET-MPI data, additionally, peak heart rate, per-
ent myocardium ischemic, percent myocardium
carred and interaction of percent myocardium
carred and peak heart rate, and interaction of rest
eart rate and history of prior CAD were significant
ndependent predictors (model chi-square 164.5,
 0.0001). The vasodilator PET model incre-
entally enhanced the clinical model with an in-
rease in model chi-square and ROC area under the
urve from 69% to 74% (p  0.006). The modeling
esults for all-cause death were very similar when
Table 3. Cox Proportional Hazards Model Predicting Cardiac Ev
All Patients (n  1
Clinical Model
 Rest LVEF
Clini
Model chi-square,
p value
92, p  0.0001
Model ROC 79%
Variables HR 95% CI
p
Value HR
Rest LVEF (per 10% EF) 0.50† 0.40–0.62 0.0001 0.77†
History of prior CAD 3.68† 1.98–6.82 0.0001 3.06†
Peripheral vascular
disease
2.06 1.18–3.62 0.02
Insulin use 2.00 1.27–2.13 0.005 1.79
Rest heart rate
(per 10/min)
1.48†
Peak stress heart rate
(per 10/min)
0.63
Percent
myocardium ischemic
(per 5% myocardium)
1.22
Percent
myocardium ﬁxed
(per 5% myocardium)
1.25†
LVEF reserve* (per 5%)
Clinical model included historical and clinical data and rest LVEF. The myocardi
between covariates are not accounted for in the above results. ‡Peak stress LV
CAD  coronary artery disease; CI  conﬁdence interval; EF  ejection fraction; Hercent myocardium abnormal was substituted for
ercent myocardium ischemic and scarred.
Further, in 985 patients, the model including
VEF reserve provided incremental value to the
est PET-MPI model for predicting all-cause
eath (model chi-square 93.4, p  0.0001, vs. 85,
 0.0001 and ROC area under the curve 83% vs.
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8529%, p 0.006, respectively). The modeling results
or all-cause death were very similar when percent
yocardium abnormal was substituted for percent
yocardium ischemic and scarred.
Risk-adjusted survival curves based on Cox mod-
ls showed that PET-MPI was able to achieve
nhanced risk stratification with respect to both CE
nd all-cause death (15). For both the primary and
econdary end points, a patient with a normal scan
ad a lower risk, and predicted risk progressively
ncreased in a patient with 10% and 20% and 30%
schemic myocardium, respectively (Fig. 3). Like-
ise, risk-adjusted survival curves (Fig. 4A with 0%
schemic myocardium and Fig. 4B with 20% isch-
mic myocardium) showed a significant separation
f survival curves for a patient with LVEF 50%,
5%, and 20%, respectively. As shown (Figs. 4A
nd 4B), survival is worse in a patient with signif-
cant ischemic burden compared to one without
schemia. Finally, there was a significant separation
f the risk-adjusted survival curves for patients with
decrease in LVEF during peak stress (LVEF
0%) compared to those without a decrease in
VEF during peak stress (Fig. 5).
I S C U S S I O N
n a large number of patients undergoing vasodilator
tress PET, our findings show that Rb-82 PET-MPI
rovides independent and incremental information for
he prediction of CE and all-cause death. Risk-
djusted survival analysis showed that both statistical
increased chi-square and ROC analysis) and clinical
nhanced risk stratification were achieved by the
schemic burden and scar on PET-MPI. The percent-
ge of ischemic or scarred myocardium on Rb-82
ET-MPI added incremental value to the clinical
ata and rest LVEF in predicting CE and all-cause
eath. Importantly, a novel finding in this study is that
VEF reserve is a significant independent predictor of
oth CE and all-cause death.
revious studies on PET-MPI. Prior studies have
valuated the prognostic value of Rb-82 PET-
PI (7–10). One study by Marwick et al. (9),
rom over a decade ago, evaluated patients with
stablished CAD or a high likelihood of CAD
ndergoing coronary angiography. This high-risk
ohort reflects the historical referral pattern to
b-82 PET, but unfortunately it does not reflect
urrent practice, which is now comprised generally
f intermediate-likelihood patients. A more con-
emporary study by Yoshinaga et al. (8) reported onSu
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853ower-risk, more representative patient cohort (sim-
lar to the SPECT literature). However, this study
as limited in size (367 patients), statistical power
only 17 hard events of cardiac death or nonfatal
I), and follow-up success (8.3% lost to follow-up
ate) (8). Also, none of the prior studies evaluated
he prognostic value of LVEF reserve in addition to
ET-MPI.
Our findings confirm and extend the results of
hese prior studies in several important ways. Firstly,
his is the largest study to date, evaluating the prog-
ostic value of MPI with PET. The study cohort is
omprised of a large number of patients with known
r suspected CAD reflecting current clinical practice
atterns in the U.S. Further, by having sufficient
ower, we can adequately model end points without
isk of overfitting or underfitting our models, thus
etter determine the incremental prognostic value of
yocardial perfusion PET imaging over historical,
linical, rest LVEF, and stress testing variables. Also,
his study showed for the first time the incremental
alue of LVEF reserve in addition to clinical, rest EF,
nd PET-MPI data. Lastly, patient imaging was
arried out using contemporary imaging technology
ith PET/CT.
ET versus SPECT MPI. Rb-82 PET-MPI offers sev-
ral technical advantages over SPECT, including
igher sensitivity as well as spatial and temporal
esolution and depth-independent attenuation correc-
ion (1). These differences in imaging characteristics
esult in improved diagnostic accuracy for diagnosing
bstructive CAD, particularly in obese individuals and
hose who are undergoing pharmacological stress
yocardial perfusion imaging (1,16,17). In addition,
he inherent ability to collect LV function data at rest
nd during peak stress seems to result in improved
etection of multivessel CAD (4). Although not
outinely available for clinical use, another advantage
f PET-MPI is its ability to quantify myocardial
lood flow, thereby allowing a better characterization
f underlying CAD (1,2,6). The findings of this and
ther studies expand the diagnostic potential of this
echnology and suggest that Rb-82 PET-MPI seems
o be an excellent alternative to vasodilator SPECT
PI that is rapid, accurate, and highly specific, and
ble to achieve similar risk stratification for future CE
nd survival. Despite these advantages over SPECT, it
s unclear at this point whether the enhanced accuracy
f PET compared with SPECT MPI is sufficient to
utweigh its greater cost, hence its general use cannot
et be justified.
alue of rest LVEF and LVEF reserve. The prognostic
alue of rest LVEF and volumes is well known (18). gn this study, rest LVEF by Rb-82 PET was
nversely and independently related to the risk of
E and all-cause death. The available evidence
uggests that post-stress LV functional assessment
dds to risk assessment by SPECT MPI (18).
ecently, peak dipyridamole stress LVEF by Rb-82
ET was shown to be independently predictive of
ll-cause death (19). These findings are likely re-
ated to the longer duration of vasodilation with
ipyridamole, allowing assessment of peak hyper-
mic LVEF information. To the best of our knowl-
dge, this is the first study showing the added utility
f LVEF reserve in addition to rest LVEF and
ET-MPI. Because of collinearity between rest
VEF and peak stress LVEF, this analysis was
erformed using rest LVEF and LVEF reserve.
asodilator LVEF reserve on Rb-82 PET is a
arker of severe and extensive obstructive CAD (3)
nd is inversely related to ischemic burden (3,20).
he results of this study extend prior results by
howing that an abnormal vasodilator LVEF re-
erve is not only a marker of anatomic obstructive
AD and ischemia but also an independent and
ncremental risk marker for future outcomes.
tudy limitations. This is a single-center observa-
ional study, with retrospective analysis of prospec-
ively collected data, with all the attendant limita-
ions and biases. The study results are most
pplicable to patients undergoing dipyridamole va-
odilator stress PET imaging and may not be
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854rcise, or dobutamine PET studies because of in-
erent differences in baseline patient risk and levels
nd duration of peak coronary flow achieved.
O N C L U S I O N S
he percentage of ischemic myocardium on vaso-
ilator stress Rb-82 PET-MPI is a powerful pre-
ictor of CE and survival in patients with known
AD or an intermediate to high pre-test likelihood
f CAD. Rb-82 PET-MPI provides significant
ncremental value over the baseline clinical vari-
bles, rest LVEF and stress data. The addition ofImpact of myocardial perfusion imag- identifying patientsncremental value to Rb-82 MPI for stratifying risk
f future serious adverse events.
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